SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-15-064326
Filing Date
2015-11-12
Accepted
2015-11-12 06:09:25
Documents
9
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v424033_10q.htm 10-Q 490846
2 EXHIBIT 31.1 v424033_ex31-1.htm EX-31.1 6754
3 EXHIBIT 32.1 v424033_ex32-1.htm EX-32.1 4128
  Complete submission text file 0001144204-15-064326.txt   4210276

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT eyeg-20150930.xml EX-101.INS 787619
5 XBRL TAXONOMY EXTENSION SCHEMA eyeg-20150930.xsd EX-101.SCH 41444
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE eyeg-20150930_cal.xml EX-101.CAL 37881
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE eyeg-20150930_def.xml EX-101.DEF 259617
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE eyeg-20150930_lab.xml EX-101.LAB 344089
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE eyeg-20150930_pre.xml EX-101.PRE 319815
Mailing Address 271 WAVERLEY OAKS ROAD SUITE 108 WALTHAM MA 02452
Business Address 271 WAVERLEY OAKS ROAD SUITE 108 WALTHAM MA 02452 781-788-9043
EYEGATE PHARMACEUTICALS INC (Filer) CIK: 0001372514 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36672 | Film No.: 151221131
SIC: 2834 Pharmaceutical Preparations